Fortive 경영진
경영진 기준 점검 2/4
Fortive CEO는 Olumide Soroye, Jun2025 에 임명되었습니다 의 임기는 1.08 년입니다. 총 연간 보상은 $14.41M, 6.5% 급여 및 93.5% 보너스(회사 주식 및 옵션 포함)로 구성됩니다. 는 $16.14M 가치에 해당하는 회사 주식의 0.085% 직접 소유합니다. 경영진과 이사회의 평균 재임 기간은 1.5 년과 5.5 년입니다.
핵심 정보
Olumide Soroye
최고경영자
US$14.4m
총 보수
| CEO 급여 비율 | 6.47% |
| CEO 재임 기간 | 1.1yrs |
| CEO 지분 보유율 | 0.08% |
| 경영진 평균 재임 기간 | 1.5yrs |
| 이사회 평균 재임 기간 | 5.5yrs |
최근 경영진 업데이트
Recent updates
내러티브 업데이트 • Jul 03
FTV: Earnings Momentum And Buybacks Will Shape Future Return Profile
Analysts have raised the Fortive fair value estimate to about $64.36 from $62.19, reflecting a series of incremental price target increases on the stock. They point to supportive demand trends in areas such as power, data centers, aerospace and defense, and infrastructure.분석 기사 • Jun 21
Fortive (FTV) Stock Could Be 15.2% Below Fair Value as Digital Growth Narrative Builds
Why Fortive Stock Is On Investors’ Radar Fortive (FTV) shares have been getting more attention after a period of positive returns, with the stock up over the past month, past 3 months, and year to date. Investors are weighing how this recent performance lines up with the company’s fundamentals and valuation. See our latest analysis for Fortive. Over the past year Fortive’s share price has built steady momentum, with a 10.18% year to date share price return and a 16.71% total shareholder...
내러티브 업데이트 • Jun 19
FTV: Future P/E Compression Will Limit Support From Ongoing Buybacks
Fortive's analyst price target moves modestly higher in this update, supported by a slightly richer fair value estimate of $53.80 as analysts factor in recent target increases from several firms and modest adjustments to revenue growth, profit margin, and future P/E assumptions. Analyst Commentary on Fortive Stock Recent research on Fortive reflects a mix of optimism and restraint, with several firms adjusting price targets and ratings as they reassess revenue, margin, and P/E assumptions.
내러티브 업데이트 • Jun 04
FTV: Buybacks And Sequential Execution Will Support Future EPS Upside
Fortive's analyst price target is modestly higher, with recent Street research pointing to a series of $1 to $7 upward target revisions as analysts highlight sequential growth and adjust assumptions around revenue, margins, and future P/E multiples. Analyst Commentary Recent Street research on Fortive has leaned constructive, with several bullish analysts adjusting targets upward and one trimming a target by a small amount.내러티브 업데이트 • May 20
FTV: Buybacks And Sequential Execution Will Support Future Earnings Quality
Fortive's analyst price target has been raised by several firms in recent research, collectively edging higher by single digits in dollar terms. Analysts point to solid sequential growth and recent company execution to support slightly higher revenue growth and P/E expectations, even as profit margin assumptions are trimmed and the discount rate is nudged up.내러티브 업데이트 • May 02
FTV: Sterilization Demand And Buybacks Will Support Future Earnings Quality
Fortive's analyst fair value estimate has been nudged up by $1 to $73 after analysts weighed a mix of recent price target increases and trims alongside recalibrated assumptions for growth, margins and future P/E levels. Analyst Commentary Recent Street research on Fortive shows a mix of target price trims and increases, with bullish analysts generally leaning toward higher fair value assumptions even as some recalibrate their models.내러티브 업데이트 • Apr 16
FTV: Future P E Compression Will Challenge Buyback Support At Current Levels
Fortive's analyst price targets have seen a mixed reset, with one firm trimming its view by $7 while several others lifted their targets by $4 to $9, as analysts factor in modest tweaks to fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Recent research on Fortive shows a mix of optimism and caution, with several firms lifting their price targets and one trimming its view by $7.Seeking Alpha • Apr 14
Fortive: Starting To Improve Its Performance
Summary Fortive has executed well post-Ralliant spin-off, delivering solid earnings and modest organic growth, supporting a fair valuation. Fortive's 2025 sales rose 2% to $4.16B, with 4Q organic growth exceeding 3%; adjusted EPS reached $2.71, up $0.30 YoY. Guidance targets 2026 adjusted EPS of $2.90–$3.00, underpinned by 2–3% organic growth, margin gains, and continued buybacks. At 19–20x forward earnings and leverage in the mid-2s, Fortive offers reasonable value, though upside is capped without stronger growth catalysts. Read the full article on Seeking Alpha내러티브 업데이트 • Apr 02
FTV: Fair Value View Balances Buybacks Against Execution And P E Compression Risks
Analysts have nudged their fair value estimate for Fortive higher to $52.50 from $51.10, reflecting updated views on revenue growth, margins, and future P/E assumptions following a mix of recent price target hikes and one downgrade across the Street. Analyst Commentary Recent Street research on Fortive shows a mixed but generally cautious tone, with a cluster of price target increases alongside at least one downgrade and a later price target cut.내러티브 업데이트 • Mar 19
FTV: Fair Value Case Weighs Buybacks Against Execution And Multiple Compression Risks
Fortive's analyst price target has been adjusted slightly lower to $51.10. Analysts point to updated fair value estimates, refined discount rate assumptions, and refreshed views on revenue growth, margins, and future P/E multiples following a series of recent price target revisions across major firms.내러티브 업데이트 • Mar 05
FTV: North American Sterilization Demand Will Support Future Earnings Quality Upside
Analysts have lifted their price targets on Fortive, supporting a move in our fair value estimate from $66.00 to $72.00. They cited updated expectations for revenue growth, profitability and a lower forward P/E multiple.내러티브 업데이트 • Feb 19
FTV: Recent Rating Shift And Buybacks Will Shape Future Return Profile
Our updated Fortive narrative reflects a higher implied price target of about $62, as analysts factor in steadier revenue growth assumptions, slightly stronger profit margins, a modestly lower discount rate, and a similar forward P/E, consistent with a series of recent price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of higher Fortive price targets, alongside at least one downgrade.내러티브 업데이트 • Feb 04
FTV: JPMorgan Downgrade And Buybacks Will Shape A Measured Return Profile
Analysts have trimmed their price target on Fortive to US$58.13, citing a slightly lower discount rate, modestly softer revenue expectations and a higher assumed profit margin supported by a reduced future P/E multiple. Analyst Commentary Recent commentary around the new US$58.13 price target reflects a mixed view on Fortive, with the latest JPMorgan downgrade underlining both execution opportunities and areas of concern for valuation and growth.내러티브 업데이트 • Jan 21
FTV: Balanced Outlook As Healthcare Demand And Buybacks Shape Future Returns
Narrative Update The analyst price target for Fortive has shifted from approximately $56.13 to $58.13, as analysts cite recent model updates and sequential improvements in North American demand for sterilization and biomedical equipment, along with higher AHS adjusted EBITDA driven by gross profit growth and lower costs. Analyst Commentary Recent research on Fortive reflects a mix of optimism on execution and caution around upside potential, which is showing up in both price target changes and rating shifts.내러티브 업데이트 • Jan 06
FTV: Fair Value View Balances Higher Demand With Margin Execution Risks
Analysts have increased their fair value estimate for Fortive from US$50.00 to US$52.00, citing refreshed models after the Q3 report and Street research that points to improved North American demand for sterilization and biomedical equipment, stronger AHS adjusted EBITDA margins, and updated price targets clustered around US$55 to US$58. Analyst Commentary Recent Street research on Fortive points to updated price targets clustered in the US$55 to US$58 range, with analysts revising their models following the Q3 report.분석 기사 • Dec 27
Estimating The Fair Value Of Fortive Corporation (NYSE:FTV)
Key Insights The projected fair value for Fortive is US$53.12 based on 2 Stage Free Cash Flow to Equity Current share...내러티브 업데이트 • Dec 15
FTV: North American Sterilization Demand Will Support Earnings Quality And Upside Potential
Analysts have modestly raised their blended price target on Fortive to about $58 per share from roughly $55, citing improved North American demand for sterilization and biomedical equipment, stronger margins in Advanced Healthcare Solutions, and updated post earnings financial models that still reflect slightly softer long term growth and profitability assumptions. Analyst Commentary Bullish analysts are pointing to a constructive risk reward profile for Fortive, highlighting that incremental execution gains and healthier end market trends can support the recent step up in valuation.내러티브 업데이트 • Oct 20
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered their fair value estimate for Fortive to $56.13 from $57.25. They cite a tougher outlook and more challenging revenue growth projections for the remainder of the year.내러티브 업데이트 • Sep 18
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered Fortive's price target to $57.25 due to skepticism over the company's ability to meet guidance amid slowing growth in its strongest segment, caution around macro headwinds post-Ralliant spinoff, and minimal near-term revenue growth. Analyst Commentary Persistent skepticism regarding Fortive's ability to achieve its full-year guidance following a cautious update and lack of supportive industry data.내러티브 업데이트 • Sep 03
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered Fortive’s target price to $60.50, citing uncertainty about achieving updated guidance following the Ralliant spin-off, ongoing topline and margin pressures, and diminished visibility post-restructuring. Analyst Commentary Bullish analysts highlight Fortive's high earnings visibility and strong recurring revenue profile (~50%+), expecting portfolio reviews and strategic focus on workflow management software and healthcare to support margin resilience.Seeking Alpha • Mar 10
Fortive Seeing Signs Of Improvement, But Valuation Doesn't Make It An Easy Call
Summary Fortive's fourth-quarter results (and full 2024 results) showed fairly ordinary performance, with revenue and margins missing targets, and the business model didn't meaningfully outperform peers through the cycle. 2025 should be a better year, and I'd expect Fortive's businesses to recover ahead of more manufacturing and machinery-focused peers. The upcoming split of Precision Technologies into Ralliant may reduce complexity but is unlikely to significantly add or destroy value, but I can see potential strategic bidders for Tektronix. Despite cautious optimism for 2025, FTV's valuation doesn't justify a premium, given its inability to outgrow inflation and deliver superior full-cycle performance. Read the full article on Seeking AlphaSeeking Alpha • Dec 11
Fortive Corporation: Undervaluation And Stability Give It An Edge (Rating Upgrade)
Summary Fortive Corporation's product innovations and increased bookings, particularly in cloud-based solutions, support a recovery by 2025 despite macro uncertainties delaying short-term growth. The company’s strong cash flow, robust liquidity, and undervaluation compared to peers justify an upgrade to a "Buy" rating. Fortive's solid balance sheet, aggressive share repurchase policy, and stable cash flow position it well for superior medium-term returns. Read the full article on Seeking AlphaCEO 보수 분석
| 날짜 | 총 보수 | 급여 | 회사 수익 |
|---|---|---|---|
| Apr 03 2026 | n/a | n/a | US$557m |
| Dec 31 2025 | US$14m | US$932k | US$533m |
| Sep 26 2025 | n/a | n/a | US$885m |
| Jun 27 2025 | n/a | n/a | US$879m |
| Mar 28 2025 | n/a | n/a | US$388m |
| Dec 31 2024 | US$8m | US$764k | US$483m |
| Sep 27 2024 | n/a | n/a | US$555m |
| Jun 28 2024 | n/a | n/a | US$661m |
| Mar 29 2024 | n/a | n/a | US$900m |
| Dec 31 2023 | US$8m | US$750k | US$408m |
| Sep 29 2023 | n/a | n/a | US$828m |
| Jun 30 2023 | n/a | n/a | US$800m |
| Mar 31 2023 | n/a | n/a | US$764m |
| Dec 31 2022 | US$7m | US$750k | US$755m |
| Sep 30 2022 | n/a | n/a | US$696m |
| Jul 01 2022 | n/a | n/a | US$659m |
| Apr 01 2022 | n/a | n/a | US$650m |
| Dec 31 2021 | US$14m | US$274k | US$580m |
보상 대 시장: Olumide의 총 보수(USD14.41M)는 US 시장에서 비슷한 규모 기업의 평균(USD14.63M) 수준입니다.
보상과 수익: Olumide의 보상은 지난 1년 동안 20% 이상 증가했습니다.
CEO
Olumide Soroye (53 yo)
1.1yrs
재임 기간
US$14,405,012
보수
Mr. Olumide O. Soroye is President, CEO & Director of Fortive Corporation from June 28, 2025. Mr. Soroye serves as Indpendent Director of Verisk Analytics, Inc. since August 19 2022. He was President and C...
리더십 팀
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| President | 1.1yrs | US$14.41m | 0.085% $ 16.1m | |
| Senior VP & CFO | 1.3yrs | US$21.41m | 0.045% $ 8.7m | |
| Senior VP & Chief Legal Officer | 10.2yrs | US$5.09m | 0.029% $ 5.5m | |
| Chief Accounting Officer | 6.8yrs | 데이터 없음 | 0.023% $ 4.3m | |
| Senior VP & Chief Technology and Business System Officer | 1.3yrs | 데이터 없음 | 데이터 없음 | |
| Vice President of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Senior VP & Chief People Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| President of Fluke & Group President of Connected Reliability Group (CRG) | no data | 데이터 없음 | 데이터 없음 | |
| President of Gordian and Group President of Facilities & Asset Lifecycle (FAL) Group | no data | 데이터 없음 | 데이터 없음 | |
| President of ASP & Group President of Infection Prevention Group (IPG) | 1.5yrs | 데이터 없음 | 데이터 없음 | |
| President of Provation & Group President of Healthcare Productivity and Quality (HPQ) Group | 1.5yrs | 데이터 없음 | 데이터 없음 | |
| Group President of Environmental | 1.5yrs | 데이터 없음 | 데이터 없음 |
1.5yrs
평균 재임 기간
53yo
평균 나이
경험이 풍부한 관리: FTV의 경영진은 경험이 부족한 것으로 간주됩니다(평균 재임 1.5 년) — 신규 팀일 수 있습니다.
이사회 구성원
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| President | 1.1yrs | US$14.41m | 0.085% $ 16.1m | |
| Independent Director | 10yrs | US$346.73k | 0.0014% $ 267.0k | |
| Independent Director | 5.3yrs | US$322.42k | 0.013% $ 2.4m | |
| Independent Director | 7.4yrs | US$347.42k | 0.0014% $ 267.0k | |
| Independent Director | 4.5yrs | US$321.20k | 0.0014% $ 267.0k | |
| Independent Director | 5.6yrs | US$335.85k | 0.0014% $ 267.0k | |
| Independent Chair of the Board | 5.9yrs | US$544.87k | 0.0014% $ 267.0k | |
| Independent Director | 1.4yrs | US$332.42k | 0.00070% $ 133.5k |
5.5yrs
평균 재임 기간
61.5yo
평균 나이
경험이 풍부한 이사회: FTV의 이사회는 경험이 있음으로 간주됩니다(평균 재임 5.5 년).
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/07/08 09:26 |
| 종가 | 2026/07/08 00:00 |
| 수익 | 2026/04/03 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Fortive Corporation는 29명의 분석가가 다루고 있습니다. 이 중 14명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| John Eade | Argus Research Company |
| Robert Mason | Baird |
| Quinn Fredrickson | Baird |